Venture Capital Pulse — 2026-05-18
This week's venture capital landscape features a significant shift in exit strategies as VCs pivot away from IPOs toward M&A and secondaries amid worsening public market conditions. PitchBook's coverage highlights a flurry of notable trends: mega-seed rounds are drawing controversy, AI IPOs are gaining momentum, and the broader market continues its AI-dominated capital concentration. The dominant story of the week is the tension between blockbuster AI exits and a cooling appetite for traditional public listings.
Venture Capital Pulse — 2026-05-18
Top Deals This Week
Sierra (Enterprise AI) — Undisclosed Round
- Sector: Enterprise AI / Conversational AI
- Lead investor(s): Not disclosed
- What they do: Sierra builds AI-powered customer service and engagement platforms for enterprises
- Why it matters: Sierra topped Crunchbase's weekly largest funding round rankings this week, leading a cohort that included space tech and biotech. The deal reinforces enterprise AI's pole position in VC allocation, with investors betting on AI that produces measurable ROI rather than frontier lab research alone.
news.crunchbase.com
s that don’t commonly show up in the lists.
news.crunchbase.com
news.crunchbase.com
Global Venture Funding In 2025 Surged As Startup Deals And Valuations Set All-Time Records
Q1 2026 Shatters Venture Funding Records As AI Boom Pushes Startup Investment To $300B
Quantum Motion — $160M Round
- Sector: Quantum Computing / Deep Tech
- Lead investor(s): Not disclosed
- What they do: Quantum Motion is building quantum computers using standard silicon chips — the same manufacturing processes used for conventional semiconductors
- Why it matters: The silicon-chip approach could dramatically lower the cost and complexity of quantum hardware, potentially making quantum computing commercially viable far sooner than exotic-material approaches. A $160M raise at this stage signals serious institutional conviction in near-term commercialization.
- Valuation: Not disclosed
Anagram Therapeutics — Biotech Series Round
- Sector: Biopharma / Drug Discovery
- Lead investor(s): Not disclosed
- What they do: Anagram Therapeutics is a biotech developing novel therapeutics (specific modality not publicly disclosed)
- Why it matters: Anagram appeared among the week's top 10 US funding rounds per Crunchbase. Biotech continues to attract significant capital despite a more selective environment, particularly for companies with differentiated platform technologies.
Astrani — Undisclosed Round
- Sector: Space Technology
- Lead investor(s): Not disclosed
- What they do: Space technology company (specific focus not publicly disclosed at time of reporting)
- Why it matters: Astrani's appearance in the top funding rounds this week underscores continued investor appetite for space tech even after True Anomaly's $600M defense-focused raise dominated headlines two weeks ago. Space remains a hot sector at the intersection of defense and commercial applications.
New Funds & LP Moves
-
Mega-Seed Controversy / Early-Stage Dynamics: New data from Carta's State of Pre-Seed Q1 2026 report (published May 14) shows pre-seed funding is hovering between $2.5B–$3B per quarter, suggesting market stabilization at the earliest stages. However, PitchBook's coverage this week flagged a growing debate: a handful of AI startups are raising nine- and ten-figure seed rounds, prompting concern among early-stage VCs who argue that bloated seed valuations are setting unrealistic benchmarks and potentially harming startups long-term. "That's a problem, not a playbook," one VC told PitchBook.
-
LP Climate Sophistication Rising: PitchBook published a Q&A with Circulate Capital this week (May 6, within our coverage window for context) noting that while LP interest in climate tech has broadly cooled, institutional LPs are becoming significantly more sophisticated in their climate portfolio analysis. Meanwhile, PitchBook's climate tech VC trends report (published May 14) confirmed Europe is now leading global VC funding for climate tech — with fewer deals but bigger bets — a structural shift from the spray-and-pray approach of 2021–2023.
Exits & Acquisitions
-
Cerebras Systems — IPO: Cerebras' public listing this week was described by PitchBook as a "blockbuster" that is "setting the stage for an AI IPO frenzy." The chip designer, known for its wafer-scale AI processors, is among the most anticipated tech IPOs of 2026. Its successful listing is expected to accelerate the IPO pipeline for other AI infrastructure companies and signal that public market appetite for AI hardware remains strong despite broader market volatility.
-
Fervo Energy — IPO: Geothermal energy company Fervo Energy went public this week, surging 35% on its IPO pop according to PitchBook. The strong debut reflects investor enthusiasm for next-generation energy infrastructure, particularly companies positioned to serve the voracious power demands of AI data centers. Fervo's enhanced geothermal systems technology has been validated through contracts with major hyperscalers.
-
Shift Away from IPOs (Broad Trend): In a notable counter-narrative to the Cerebras and Fervo debuts, LiveMint reported this week that VCs are broadly stepping back from IPOs as their primary exit route, turning instead to secondary transactions, founder buybacks, and M&A as public market conditions remain unpredictable. This bifurcation — blockbuster AI listings succeeding while the average VC portfolio company struggles to go public — is reshaping exit strategy across the industry.
Sector Spotlight
AI Infrastructure: Where the Real Money Is Flowing
This week's deal flow and editorial coverage converge on a clear signal: AI infrastructure — not applications, not agents — is commanding the largest checks and generating the most exit activity.
The Cerebras IPO is the clearest proof point. Its successful public listing validates the thesis that AI chip and infrastructure companies can command premium valuations even in a selective public market. Fervo's energy IPO is the infrastructure story's B-side: the data centers running AI need power, and investors are following the wattage.
At the funding stage, PitchBook's ongoing coverage of the OpenAI–Anthropic rivalry (updated May 15) highlights that Q1 2026 AI funding blew past the entire 2025 total, with just three deals accounting for 67% of all AI capital deployed. This extreme concentration means most AI funding activity is cosmetically diversified but economically top-heavy.
The humanoid robotics segment — another infrastructure-adjacent bet — drew scrutiny in PitchBook's weekend analysis (May 15), which examined "the limits of VC's humanoid bet." While humanoid robots attracted significant capital in 2024–2025, analysts are now questioning whether the timelines are realistic and whether VC return profiles can survive 10–15 year commercialization cycles.
What this means for founders and investors:
- If you're building AI infrastructure (chips, energy, networking, data), the capital environment remains exceptionally favorable
- Application-layer AI companies face more scrutiny on differentiation and defensibility
- The mega-seed phenomenon is inflating early-stage valuations for AI startups, creating potential down-round risk for companies that don't grow into aggressive benchmarks
- Exit optionality is narrowing for non-AI companies; VCs are increasingly relying on M&A and secondaries rather than public listings
What to Watch Next Week
-
SpaceX IPO Filing Reverberations: SpaceX's $1.75T IPO filing is rewriting the math for all space-sector investors and is expected to significantly reshape the VC secondaries market, which currently counts SpaceX, OpenAI, and Anthropic as its most-traded names. Watch for secondary market pricing shifts as the IPO timeline becomes clearer.
-
PitchBook Global League Tables Q1 2026: Published May 15, the global league tables are fresh data on which firms led deal activity in Q1. Expect follow-on analysis and media coverage dissecting which investors dominated the AI mega-round era and which are losing ground.
-
LP Co-Investment Dynamics: PitchBook's May 11 coverage flagged that LPs are "fighting tooth and nail" for co-investment allocations in foundational AI deals. Next week should bring further clarity on whether GP-led secondaries and structured co-investments will become a defining feature of the 2026 vintage.
-
Europe's Tech Sovereignty Policy Impact: PitchBook noted May 11 that Europe's tech sovereignty push is "giving VCs pause." With the Trump-Xi summit in Beijing also being watched by private markets (covered May 12), geopolitical developments could reshape cross-border investment flows, particularly for AI and semiconductor deals with dual-use implications.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
